Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricDXCMDexcomGEHCGE HealthCareRMDResMed
Snapshot
Price$83.47$71.20$213.94
Market cap$27.49B$29.82B$30.41B
Valuation
P/E34.9x17.4x20.4x
Forward P/E25x19.8x17.5x
Growth
Revenue growth16.1%6.0%10.3%
EPS growth77.5%-12.3%16.5%
Profitability
Net margin19.3%9.1%27.4%
ROE33.8%18.8%24.4%
Balance sheet & cash
Debt / equity0.47x0.97x0.11x
Free cash flow yield1.8%7.7%3.8%
Dividend yield—0.2%1.2%
Verdict
Investment ratingFavorable· 70Neutral· 51Strong· 75

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearDXCMtoday $83GEHCtoday $71RMDtoday $214
2027$111.09 – $162.93+95% CAGR$54.47 – $79.89+12% CAGR$186.88 – $274.09+28% CAGR
2028$197.13 – $289.12+86% CAGR$55.56 – $81.48+7% CAGR$217.66 – $319.24+22% CAGR
2029$349.80 – $513.04+83% CAGR$56.67 – $83.11+5% CAGR$253.51 – $371.81+20% CAGR
2030$620.72 – $910.39+82% CAGR$57.80 – $84.78+4% CAGR$295.26 – $433.05+19% CAGR
2031$1,101.47 – $1,615.49+81% CAGR$58.96 – $86.47+4% CAGR$343.89 – $504.38+19% CAGR
5-yr CAGR67.5% – 80.9%-3.7% – 4.0%10.0% – 18.7%